U.S. Court of Appeals for the Federal Circuit, 2025

Novartis Pharmaceuticals Corporation v. Msn Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation v. Msn Pharmaceuticals, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided June 13, 2025

Novartis Pharmaceuticals Corporation v. Msn Pharmaceuticals, Inc.

Opinion

Case: 25-1722 Document: 21 Page: 1 Filed: 06/13/2025

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ IN RE: ENTRESTO (SACUBITRIL/VALSARTAN) -------------------------------------------------- NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee v. MSN PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD., MSN LIFE SCIENCES PRIVATE LTD., Defendants-Appellants ______________________ 2025-1722, 2025-1723 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:20-md-02930-RGA, 1:19-cv- 02053-RGA, Judge Richard G. Andrews. ______________________ ORDER The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 25-1722 Document: 21 Page: 2 Filed: 06/13/2025

2 NOVARTIS PHARMACEUTICALS CORPORATION V. MSN PHARMACEUTICALS, INC.

(2) Each side shall bear their own costs.

FOR THE COURT

June 13, 2025 Date

ISSUED AS A MANDATE: June 13, 2025

Case-law data current through December 31, 2025. Source: CourtListener bulk data.